ArticleBMC medical imaging2026
Quantitative assessment of coronary peri-vascular fat attenuation index using dual-layer spectral CT for differentiating high-risk plaques in coronary artery disease.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPerivascular adipose tissue (PCAT) inflammation contributes to plaque vulnerability in coronary artery atherosclerotic heart disease (CHD). The fat attenuation index (FAI) has emerged as a non-invasive marker of vascular inflammation. However, its association with plaque characteristics, particularly high-risk plaques (HRPs), remains insufficiently understood. This study evaluated coronary peri-vascular FAI using dual-layer spectral CT (SDCT) and its relationship with plaque calcification and HRP identification.
methodsA retrospective analysis of 182 patients with CHD and 312 plaques was conducted. FAI was measured on 120 kVp images, virtual monoenergetic images, and effective atomic number (Eff-Z) images across energy levels from 40 keV to 100 keV. The spectral slope (λHU) was also calculated. The relationship between FAI and plaque calcification was assessed, and differences in quantitative parameters between high-risk and non-high-risk plaque groups were used to determine optimal cut-off values for differentiating HRPs.
resultsAs plaque calcification increased, FAI values generally decreased. The fat attenuation values around HRPs were significantly higher than those around non-HRPs. Additionally, λHu (λ40-70 keV, λ40-100 keV) and Eff-Z values were significantly higher in HRPs compared to non-HRPs (all p < 0.001). Multivariate logistic regression identified FAI at 40 keV, λ40-70 keV, and Eff-Z as independent predictors for HRP diagnosis. The combined model of these parameters had the highest diagnostic efficacy, with an AUC of 0.881, sensitivity of 87.1%, and specificity of 75.0%.
conclusionFAI assessed using SDCT demonstrates enhanced discrimination of plaque composition and characteristics compared to conventional CT. The combined model of FAI40keV, λ40–70 keV, and Eff-Z shows the highest discriminative ability for high-risk plaque features, suggesting potential value for non-invasive plaque characterization that warrants prospective validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.